Preview from the original posting — full details are on the employer's site.
About Maxion Maxion has engineered a new class of biologics by harnessing knottins, one of nature’s most potent modulators of ion channels and G protein-coupled receptors (GPCR). Combining a knottin with an antibody’s advantageous drug properties, we are developing transformative treatments that reach new levels of specificity and durability for patients with ion channel and GPCR-driven diseases. Initially focused on immunological diseases, heart disorders and chronic pain, our pipeline of prop…
Compliance
New Entrant Eligible (2026)
First seen
14 Aug 2026
Our AI rewrites your CV for this exact role and injects the visa eligibility language recruiters need to see.
Get started free